[1]
Kittipadakul, S. et al. 2026. Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Medicine Research. 18, 5 (Jan. 2026), 301–312. DOI:https://doi.org/10.14740/jocmr6529.